The Indian Council of Medical Research has published a tender for "S P2 5mg 31 TSSSVTKSYISSQTNGEMGQL 51,S P2 5mg 31 TSSSVTKSYISSQTNGEMGQL 51,S P2 5mg 31 TSSSVTKSYISSQTNGEMGQL 51,S P2 5mg 31 TSSSVTKSYISSQTNGEMGQL 51,S P2 5mg 31 TSSSVTKSYISSQTNGEMGQL 51,S P2 5mg 31 TSSSVTKSYISSQTNGEMGQL 51,S P2 5mg 31 TSSSVTKSYISSQTNGEMGQL 51,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,s P1 5mg 45 NGETGQLVHRFTVPAPVVII 64,s P1 5mg 45 NGETGQLVHRFTVPAPVVII 64,s P1 5mg 45 NGETGQLVHRFTVPAPVVII 64,s P1 5mg 45 NGETGQLVHRFTVPAPVVII 64,s P1 5mg 45 NGETGQLVHRFTVPAPVVII 64,s P1 5mg 45 NGETGQLVHRFTVPAPVVII 64,s P1 5mg 45 NGETGQLVHRFTVPAPVVII 64,s P1 5mg" on the 27 Jan 2026. This tender belongs to Medicines category. The vendors interested in this tender and related Medicines tenders can obtain further details by exploring Tendersniper web portal. Tendersniper sends regular tender alerts by email specifically addressing the user requirements (i.e., keywords, location and value range). Government business is a growing area of opportunity. The businesses are encouraged to actively monitor tender opportunities and participate in them to grow their business.
| Tender Title | S P2 5mg 31 TSSSVTKSYISSQTNGEMGQL 51,S P2 5mg 31 TSSSVTKSYISSQTNGEMGQL 51,S P2 5mg 31 TSSSVTKSYISSQTNGEMGQL 51,S P2 5mg 31 TSSSVTKSYISSQTNGEMGQL 51,S P2 5mg 31 TSSSVTKSYISSQTNGEMGQL 51,S P2 5mg 31 TSSSVTKSYISSQTNGEMGQL 51,S P2 5mg 31 TSSSVTKSYISSQTNGEMGQL 51,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,S P3 5mg 40 ISSQTNGEMGQLVHRFTVPA 59,s P1 5mg 45 NGETGQLVHRFTVPAPVVII 64,s P1 5mg 45 NGETGQLVHRFTVPAPVVII 64,s P1 5mg 45 NGETGQLVHRFTVPAPVVII 64,s P1 5mg 45 NGETGQLVHRFTVPAPVVII 64,s P1 5mg 45 NGETGQLVHRFTVPAPVVII 64,s P1 5mg 45 NGETGQLVHRFTVPAPVVII 64,s P1 5mg 45 NGETGQLVHRFTVPAPVVII 64,s P1 5mg |
|---|---|
| Tender Description | m p1 5mg 16 sisassttgvamhtstsssvt 36 , m p2 5mg 8 vlllsaivsisassttgvamh 28 , m p3 5mg 12 saivsisassttgvamhtsts 32 , n p1 5mg 16 sisalsttevamhtstsssvt 36 , n p2 5mg 8 vlllsaivsisalsttevamh 28 , n p3 5mg 12 saivsisalsttevamhtsts 32 , s p1 5mg 45 /item category ngemgqlvhrftvpapvvii 64 , s p2 5mg 31 tsssvtksyissqtngemgql 51 , s p3 5mg 40 issqtngemgqlvhrftvpa 59 , s p1 5mg 45 ngetgqlvhrftvpapvvii 64 , s p2 5mg 31 tsssvtksyissqtngetgql 51 , s p3 5mg 40 issqtngetgqlvhrftvpa 59 , coombs anti igg 288 , liss by coombs 288 |
| Comments | m p1 5mg 16 sisassttgvamhtstsssvt 36 , m p2 5mg 8 vlllsaivsisassttgvamh 28 , m p3 5mg 12 saivsisassttgvamhtsts 32 , n p1 5mg 16 sisalsttevamhtstsssvt 36 , n p2 5mg 8 vlllsaivsisalsttevamh 28 , n p3 5mg 12 saivsisalsttevamhtsts 32 , s p1 5mg 45 /item category ngemgqlvhrftvpapvvii 64 , s p2 5mg 31 tsssvtksyissqtngemgql 51 , s p3 5mg 40 issqtngemgqlvhrftvpa 59 , s p1 5mg 45 ngetgqlvhrftvpapvvii 64 , s p2 5mg 31 tsssvtksyissqtngetgql 51 , s p3 5mg 40 issqtngetgqlvhrftvpa 59 , coombs anti igg 288 , liss by coombs 288 |
| Published Date | |
|---|---|
| Due Date | 18 Feb 2026 00:00:00 |
| Estimated Value | 0.0 |
|---|---|
| EMD | 0 INR |
| Processing Fee | 0 INR |